India will produce about 300 million doses of Russia's Sputnik V coronavirus vaccines next year, a Russian official was quoted as saying. According to Reuters, this new number is nearly three times the previously known quantity as deals have been signed with more manufacturers.

India to produce about 300 mn doses of Russian vaccine; new deals signed

As the race to produce and distribute vaccines around the world enters a new stage with the authorization of US pharma giant Pfizer and Germany's BioNTech, Kremlin said today that "dirty methods" were being used to discredit the Russian Sputnik V vaccine to block its access in other markets.

'Dirty methods' being used to discredit Sputnik V vaccine: Kremlin

Russia's Sputnik V coronavirus vaccine developers said today that it is "95 per cent effective" after second interim analysis of clinical trial data. Also Read | Russia's Sputnik V vaccine to be manufactured in India Watch: The state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said the vaccine will be available in the international markets for less than $10 per dose and it can be stored between two and eight degrees Celsius (between 35.

Sputnik V coronavirus vaccine to cost less than $10 per dose: Russia

Russia's Sputnik V Covid vaccine will be manufactured in India, among other countries and current clinical trials are underway as well in the country. CEO of Russian Direct Investment Fund (RDIF), Kirill Dmitriev, said, We are ready to start deliveries of the Sputnik V vaccine to foreign markets thanks to partnerships with manufacturers in India, Brazil, South Korea, China, and four other countries.

Russia's Sputnik V vaccine to be manufactured in India